Guifen Qiang Selected Research

Guifen Qiang Research Topics

Disease

6	Obesity 01/2024 - 07/2016
5	Insulin Resistance 11/2022 - 07/2016
4	Fibrosis (Cirrhosis) 01/2024 - 06/2012
4	Body Weight (Weight, Body) 01/2024 - 01/2021
4	Hyperglycemia 11/2022 - 07/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2017
2	Non-alcoholic Fatty Liver Disease 09/2023 - 01/2023
2	Atrophy 11/2022 - 01/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 04/2014
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 04/2014 - 06/2012
1	Polydipsia 01/2024
1	Urethritis 01/2024
1	Polyuria 01/2024
1	Hyperphagia (Overeating) 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Infections 11/2022
1	Parkinson Disease (Parkinson's Disease) 05/2021
1	Huntington Disease (Huntington's Disease) 05/2021
1	Alzheimer Disease (Alzheimer's Disease) 05/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021
1	Glucose Intolerance 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2017
1	Hypertrophy 01/2017
1	Lipodystrophy 07/2016
1	Acute-Phase Reaction 01/2016
1	Hyperproinsulinemia 06/2014
1	Abscess 04/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Liver Diseases (Liver Disease) 06/2012

Drug/Important Bio-Agent (IBA)

6	LipidsIBA 01/2024 - 03/2020
5	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 06/2017
4	salvianolic acid AIBA 01/2020 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2018
3	puerarinIBA 01/2024 - 01/2018
3	Insulin (Novolin)FDA Link 01/2021 - 04/2014
3	Streptozocin (Streptozotocin)FDA Link 01/2017 - 06/2012
2	CollagenIBA 01/2024 - 01/2014
2	UrotensinsIBA 11/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2017
2	Insulin ReceptorIBA 01/2019 - 07/2016
2	CytokinesIBA 01/2018 - 01/2016
2	Sucrose (Saccharose)IBA 01/2014 - 06/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024
1	Tribulus extractIBA 01/2024
1	palmatineIBA 01/2024
1	turmeric extractIBA 01/2024
1	BerberineIBA 01/2024
1	CurcuminIBA 01/2024
1	IronIBA 01/2024
1	Vitamin B 6IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2023
1	kaempferolIBA 09/2023
1	FlavonoidsIBA 09/2023
1	Sirtuin 1IBA 09/2023
1	SaponinsIBA 01/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Neutralizing AntibodiesIBA 11/2022
1	Virulence Factors (Pathogenicity Factors)IBA 11/2022
1	aureolysinIBA 11/2022
1	GlucocorticoidsIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021
1	CholesterolIBA 05/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Toll-Like Receptor 3IBA 01/2021
1	NAD (NADH)IBA 01/2020
1	Materia Medica (Homeopathic Remedies)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	ChemokinesIBA 01/2018
1	ML-265IBA 06/2017
1	Pyruvate KinaseIBA 06/2017
1	AlbuminsIBA 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	AdipokinesIBA 07/2016
1	ProinsulinIBA 06/2014
1	AcidsIBA 01/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2014
1	Hematoxylin (Haematoxylon)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	picric acid (picrate)IBA 06/2012
1	Valsartan (Vals)FDA Link 06/2012

Therapy/Procedure

3	Therapeutics 01/2024 - 04/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 01/2015
1	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 01/2024